Premium
Antibiotic Treatment of Pneumonia
Author(s) -
Clarke C. W.,
Marlin G. E.
Publication year - 1982
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1982.tb02435.x
Subject(s) - cefoxitin , medicine , penicillin , erythromycin , clindamycin , microbiology and biotechnology , metronidazole , antibiotics , pneumonia , cephalosporin , bacteroides fragilis , anaerobic bacteria , cloxacillin , biology , bacteria , staphylococcus aureus , genetics
Summary Anaerobic pneumonia B. fragilis not involved– penicillin alternatives – clindamycin, cephalosporins, erythromycin B. fragilis involved – clindamycin, cefoxitin + metronidazole Chronic destructive pneumonia –penicillin, cefoxitin and metronidazole Summary: Acute, fulminating pneumonia–benzylpenicillin, cloxacillin, aminoglycoside erythromycin after 24 hours and negative bacteriology and clinical response–add erythromycin penicillin hypersensitivity–cephalosporins and cephamycins, erythromycin There are many other specific organisms, e.g. M. tuberculosis, and opportunistic pathogens causing pneumonia and this subject has been reviewed extensively. 26, 27 These organisms will require specific antibiotic therapy.